Please assess the completion status of the following clinical trial:

Trial Title: Probiotics in the Reduction of Antibiotic Associated Diarrhea

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Admitted to Good Samaritan Hospital~* Placed on pneumonia order set~* Age 18+~Exclusion Criteria:~* Patient with inadequate coherency to understand consent~* Active Diarrhea at admission~* Non-controlled intestinal disease~* Documented positive C. difficile infection within the 3 months before enrollment~* Antibiotic use at hospital admission~* Immunosuppressive therapy~* Pregnancy~* Allergic to ingredients in Florajen-3~* Allergic to ingredients in placebo~* Immunocompromised state including:~* HIV with a low CD4 count~* Active malignancy receiving chemotherapy~* Medications including long-term steroids (\>2 weeks), and disease modifying biologic agents~* Acquired immune deficiency~* Unable to take oral medication~* Less than 4 doses of probiotic or placebo~* Taking probiotic in the past 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 120 Years
- Healthy Volunteers: f

Study Arms:
- Probiotic (Type: ACTIVE_COMPARATOR): Treatment will be initiated within 48 hours of the first antibiotic and will be administered twice a day for 20 days. The treatment is Florajen-3. The ingredients in Florajen-3 are:~Lactobacillus acidophilus-over 7.5 billion Bifidobacterium lactis-over 6.0 billion Bifidobacterium longum-over 1.5 billion
- Placebo (Type: PLACEBO_COMPARATOR): Placebo will be initiated within 48 hours of the first antibiotic and will be administered twice a day for 20 days. The ingredients in the placebo are:~Rice maltodextrin

Based on this trial design, predict the completion outcome and termination type (if applicable).